Phase 3 trials are ongoing, and without completed large-scale safety and efficacy data, the compound cannot be considered ready for routine clinical use
In addition, the use, administration and discontinuation of use, of any vitamin supplements purchased on this website should be performed only under the guidance of your physician
If the committee votes favorably and the FDA adopts the recommendation, BPC-157 could return to Category 1 status, allowing 503A compounding pharmacies to prepare it against valid prescriptions
No, it does not stimulate IGF-1 or muscle growth its effects are limited to fat metabolism pathways
: BPC-157
Our clinics Our providers are available 7 days a week for scheduled and walk-in visits, with over 190 services offered, including management of chronic conditions